Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 2:24 pm Unchanged | 2024-09-30 | 13G | TNF Pharmaceuticals, Inc. TNFA | GLOBAL X MANAGEMENT CO LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-05-30 4:05 pm Purchase | 2024-05-23 | 13D | MyMD Pharmaceuticals, Inc. MYMD | PharmaCyte Biotech Inc. PMCB | 11,563,878 83.400% | 11,563,878 (New Position) | Filing History |
| 2024-02-14 3:13 pm Purchase | 2023-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | GLOBAL X MANAGEMENT CO LLC | 103,616 6.110% | 103,616 (New Position) | Filing History |
| 2024-02-14 11:27 am Purchase | 2023-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | Iroquois Capital Management LLC | 168,853 4.990% | 109,815 (+186.01%) | Filing History |
| 2023-02-14 07:40 am Sale | 2022-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | Iroquois Capital Management LLC | 59,038 6.470% | -13,582 (-18.70%) | Filing History |
| 2022-09-08 4:22 pm Purchase | 2022-06-07 | 13D | MyMD Pharmaceuticals, Inc. MYMD | DUFFEY SAMUEL S | 74,727 5.860% | 74,727 (New Position) | Filing History |
| 2022-02-23 4:45 pm Purchase | 2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | Iroquois Capital Management LLC | 72,620 9.560% | 72,620 (New Position) | Filing History |
| 2022-02-11 07:17 am Purchase | 2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | Mitchell P. Kopin | 12,165 1.000% | 12,165 (New Position) | Filing History |
| 2022-01-11 4:30 pm Unchanged | 2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD | MAINFIELD ENTERPRISES INC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-04-26 6:29 pm Purchase | 2021-04-16 | 13D | MyMD Pharmaceuticals, Inc. MYMD | Williams Caroline C | 167,339 13.160% | 167,339 (New Position) | Filing History |
| 2021-02-22 09:56 am Purchase | 2020-12-31 | 13G | TNF Pharmaceuticals, Inc. TNFA | Iroquois Capital Management LLC | 52,027 9.990% | 17,101 (+48.96%) | Filing History |
| 2021-02-18 2:22 pm Purchase | 2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA | MAINFIELD ENTERPRISES INC | 18,018 5.800% | 18,018 (New Position) | Filing History |
| 2021-01-29 06:31 am Unchanged | 2020-12-31 | 13G | TNF Pharmaceuticals, Inc. TNFA | Mitchell P. Kopin | 24,324 7.500% | 0 (Unchanged) | Filing History |
| 2020-11-20 4:06 pm Purchase | 2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA | Mitchell P. Kopin | 24,324 7.500% | 24,321 (+748340.00%) | Filing History |
| 2020-11-19 08:16 am Purchase | 2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA | Iroquois Capital Management LLC | 34,926 9.990% | 34,926 (New Position) | Filing History |
| 2020-05-26 06:23 am Unchanged | 2020-05-14 | 13G | TNF Pharmaceuticals, Inc. TNFA | Mitchell P. Kopin | 3 0.003% | 0 (Unchanged) | Filing History |
| 2020-05-05 2:15 pm Sale | 2020-04-30 | 13G | TNF Pharmaceuticals, Inc. TNFA | Hudson Bay Capital Management LP | 31 0.040% | -4,456 (-99.30%) | Filing History |
| 2020-04-20 11:47 am Purchase | 2020-04-17 | 13G | AKERS BIOSCIENCES INC AKER | ALPHA CAPITAL ANSTALT | 200,000 4.205% | 86,430 (+76.10%) | Filing History |
| 2020-04-17 4:15 pm Sale | 2020-04-07 | 13G | TNF Pharmaceuticals, Inc. TNFA | Mitchell P. Kopin | 3 0.010% | -978 (-99.67%) | Filing History |